
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 24.290 | 24.580 | 0.290 |
Bonds | 75.700 | 75.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 100.806 | 17.064 |
Price to Book | 7.250 | 2.198 |
Price to Sales | 3.525 | 1.555 |
Price to Cash Flow | - | 9.753 |
Dividend Yield | - | 2.744 |
5 Years Earnings Growth | - | 11.134 |
Name | Net % | Category Average |
---|---|---|
Government | 57.440 | 33.976 |
Corporate | 21.305 | 47.843 |
Cash | 10.955 | 16.877 |
Securitized | 9.463 | 6.704 |
Derivative | 0.838 | 11.410 |
Number of long holdings: 117
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Bundei 0,5% Ap30 Eur | DE0001030559 | 4.59 | 99.96 | -0.53% | |
Obligacionesei 1% Nv30 Eur | ES00000127C8 | 3.45 | 101.05 | 0.00% | |
France (Republic Of) 0% | FR0128690700 | 3.20 | - | - | |
France (Republic Of) 0% | FR0128983899 | 2.84 | - | - | |
Rheinland-Pfalz (Land) 2.375% | DE000RLP1593 | 2.52 | - | - | |
Netherlands (Kingdom Of) 0% | NL0015002BT3 | 2.50 | - | - | |
Finland 1.375 15-Apr-2027 | FI4000527551 | 2.12 | 99.360 | 0.00% | |
GlaxoSmithKline Capital PLC 4% | XS0222383027 | 1.99 | - | - | |
European Union 0% | EU000A3L6N78 | 1.78 | - | - | |
Belgium (Kingdom Of) 0% | BE0312805774 | 1.77 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch Bond Opportuni | 6.19B | 1.42 | 3.00 | 3.06 | ||
Flossbach von Storch Bond Opportune | 6.19B | 1.25 | 2.49 | 2.55 | ||
LU1481584016 | 6.19B | 1.43 | 3.00 | 3.06 | ||
LU1481583711 | 6.19B | 1.26 | 2.48 | 2.55 | ||
LU1748855837 | 6.19B | 1.35 | 2.79 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review